Skip to main content

NextGen Clinical Trial Investigator Training - Session 2, August 11

The NextGen Clinical Trial Investigator Training is a five-session educational program designed for faculty who are either involved in clinical trials or who would like to become involved. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University in St. Louis, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Timeframe: Five weeks, starting Aug. 4 through Sept. 1, 4:30 to 7:30 p.m.

August 4 - Session 1: Good Clinical Practice & Team Science
August 11 - Session 2: What is a Clinical Trial?
August 18 - Session 3: Patient & Community Engagement & Responsible Conduct of Research
August 25 - Session 4: Research Funding & Team Management
September 1 - Session 5: Institutional Resources

 

Session 2: What is a Clinical Trial?

Barohn Headshot
Barohn
Conducting and Obtaining Informed ConsentRick Barohn, MD, Executive Vice Chancellor for Health Affairs, and Executive Director of NextGen Precision Health, University of Missouri-Columbia
Miller Headshot
Miller
Sources of Bias & Error in Clinical TrialsJ. Philip Miller, PhD, Professor of Biostatistics and Medicine, Institute for Informatics, Washington University in St. Louis
Ma Headhsot
Ma
Jones Headshot
Jones
Audit Ready … No SweatRichard Ma, MD, Gregory L. and Ann L. Hummel Distinguished Professor in Orthopaedic Surgery and Division Chief of Sports Medicine, Department of Orthopaedic Surgery, University of Missouri-Columbia, and Vicki Jones, Research Project Analyst, Department of Orthopaedic Surgery, University of Missouri-Columbia
Barohn Headshot
Barohn
Manrique Headshot
Manrique
Kumar Headshot
Kumar
Lenze Headshot
Lenze

 

Lessons Learned: Panel Discussion – Rick Barohn, MD, Executive Vice Chancellor for Health Affairs, and Executive Director of NextGen Precision Health, University of Missouri-Columbia; Camila Manrique, MD, Thomas W. Burns, MD, Distinguished Professor in Diabetes, Department of Medicine, University of Missouri-Columbia;  Parvesh Kumar, MD, Associate Dean of Clinical & Translational Research, University of Missouri-Columbia School of Medicine; and Eric Lenze, MD, Wallace and Lucille K. Renard Professor of Psychiatry and Director of the Healthy Mind Lab, Washington University in St. Louis.